Using a second-person approach to identify disease-specific profiles of social behavior in frontotemporal dementia and Alzheimer's disease

Cortex ◽  
2020 ◽  
Vol 133 ◽  
pp. 236-246
Author(s):  
Mandy Visser ◽  
Stephanie Wong ◽  
Simone Simonetti ◽  
Jessica L. Hazelton ◽  
Emma Devenney ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Social Behavior ◽  
Frontotemporal Dementia ◽  
Second Person ◽  
Disease Specific

Disease-specific patterns of cortical and subcortical degeneration in a longitudinal study of Alzheimer's disease and behavioural-variant frontotemporal dementia

NeuroImage ◽  
2017 ◽  
Vol 151 ◽  
pp. 72-80 ◽  
Author(s):  
Ramon Landin-Romero ◽  
Fiona Kumfor ◽  
Cristian E. Leyton ◽  
Muireann Irish ◽  
John R. Hodges ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Longitudinal Study ◽  
Frontotemporal Dementia ◽  
Disease Specific

scholarly journals P3-282: Apolipoprotein E4 allele and grey matter atrophy in frontotemporal dementia and Alzheimer's disease: A disease-specific regional effect

2008 ◽  
Vol 4 ◽  
pp. T605-T605
Author(s):  
Keith A. Vossel ◽  
Federica Agosta ◽  
Anna M. Karydas ◽  
Adam L. Boxer ◽  
Stephen J. Bonasera ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Frontotemporal Dementia ◽  
Grey Matter ◽  
Regional Effect ◽  
Apolipoprotein E4 ◽  
E4 Allele ◽  
Grey Matter Atrophy ◽  
Disease Specific

scholarly journals Apolipoprotein E ε4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia

2009 ◽  
Vol 106 (6) ◽  
pp. 2018-2022 ◽  
Author(s):  
Federica Agosta ◽  
Keith A. Vossel ◽  
Bruce L. Miller ◽  
Raffaella Migliaccio ◽  
Stephen J. Bonasera ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Apolipoprotein E ◽  
Frontotemporal Dementia ◽  
Brain Atrophy ◽  
Specific Effects ◽  
Disease Specific

Dementia 1: Defining Dementia, Alzheimer’s Disease and Frontotemporal Dementia (DRAFT)

2018 ◽  
Author(s):  
Tamara Kaplan ◽  
Tracey Milligan
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Social Behavior ◽  
Frontotemporal Dementia ◽  
Neurofibrillary Tangles ◽  
Repetitive Behaviors ◽  
Behavioral Changes ◽  
Cognitive Domains ◽  
Pathologic Features ◽  
Visuospatial Processing

The video in this chapter explores dementia, and focuses on definitions of dementia, Alzheimer’s disease and Frontotemporal Dementia. Dementia is defined as a cognitive decline in one or more cognitive domains including memory, language, attention, visuospatial processing and social behavior. Two hallmark pathologic features of Alzheimer’s disease (AD) are plaques, which are formed from amyloid and neurofibrillary tangles, which involve tau, whereas symptoms of Frontotemporal Dementia (FTD) may include behavioral changes, apathy and disinhibition and ritualistic or repetitive behaviors. Language may also be affected, and this can be a presenting symptom.

Disease-specific profiles of apathy in Alzheimer’s disease and behavioural-variant frontotemporal dementia differ across the disease course

2019 ◽  
Vol 267 (4) ◽  
pp. 1086-1096 ◽  
Author(s):  
Grace Wei ◽  
Muireann Irish ◽  
John R. Hodges ◽  
Olivier Piguet ◽  
Fiona Kumfor
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Frontotemporal Dementia ◽  
Disease Course ◽  
Disease Specific

Distinct social-behavioral changes in frontotemporal dementia and early onset Alzheimer's disease

2014 ◽  
Author(s):  
Joseph P. Barsuglia ◽  
Michelle J. Mather ◽  
Hemali V. Panchal ◽  
Aditi Joshi ◽  
Elvira Jimenez ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Frontotemporal Dementia ◽  
Early Onset ◽  
Behavioral Changes ◽  
Early Onset Alzheimer’S Disease

Tau Oligomer Induced HMGB1 Release Contributes to Cellular Senescence and Neuropathology Linked to Alzheimer's Disease and Frontotemporal Dementia

2020 ◽  
Author(s):  
Sagar Gaikwad ◽  
Nicha Puangmalai ◽  
Alice Bittar ◽  
Mauro Montalbano ◽  
Stephanie Garcia ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Frontotemporal Dementia ◽  
Cellular Senescence

scholarly journals Death Rate Due to COVID-19 in Alzheimer’s Disease and Frontotemporal Dementia

2020 ◽  
Vol 78 (2) ◽  
pp. 537-541
Author(s):  
Jordi A. Matias-Guiu ◽  
Vanesa Pytel ◽  
Jorge Matías-Guiu
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Frontotemporal Dementia ◽  
Death Rate ◽  
Case Series ◽  
Care Homes ◽  
Relevant Factor ◽  
Increased Risk ◽  
Care Facilities ◽  
Probability Of Death

We aimed to evaluate the frequency and mortality of COVID-19 in patients with Alzheimer’s disease (AD) and frontotemporal dementia (FTD). We conducted an observational case series. We enrolled 204 patients, 15.2% of whom were diagnosed with COVID-19, and 41.9% of patients with the infection died. Patients with AD were older than patients with FTD (80.36±8.77 versus 72.00±8.35 years old) and had a higher prevalence of arterial hypertension (55.8% versus 26.3%). COVID-19 occurred in 7.3% of patients living at home, but 72.0% of those living at care homes. Living in care facilities and diagnosis of AD were independently associated with a higher probability of death. We found that living in care homes is the most relevant factor for an increased risk of COVID-19 infection and death, with AD patients exhibiting a higher risk than those with FTD.

Sign in / Sign up

Export Citation Format

Share Document